Jun Yasuda proposed that NLK might function as a tumor suppressor in colon cancer by inhibiting the Wnt/β-catenin pathway, which suppresses the transcriptional activity of the β-catenin/T-cell factor (TCF) complex by phosphorylating TCF. This evidence concerns the gene NLK and malignant colon neoplasm.